Loading…
Global business process management and IT services company providing outsourced finance, supply chain and digital/AI transformation services to enterprises.
Global business process management and IT services company providing outsourced finance, supply chain and digital/AI transformation services to enterprises.
Runs clients' finance, supply-chain and insurance back-office processes under multi-year contracts, charged per transaction, per person or as a fixed fee, so existing clients' volumes sustain it. It began in 1997 as General Electric's in-house back office and was later spun out. Most of its staff sit in India and other lower-cost centres.
Moat: narrow (switching costs, process know-how, scale). Long-term outsourcing contracts embedded in client back-office processes are costly and disruptive to switch.
Headquarters: New York, New York, USA (operations centered in India) · Founded: 1997 · Employees: 146,500
Size Genpact (G) is a United States Industrials company (Miscellaneous Commercial Services) with a market value of $7.07B, the 955th largest of 3,117 United States companies the cockpit tracks. Shares closed at $42.27 on 6 Nov 2026.
Performance Over six months the shares gained 29.8%, against +6.0% for the median peer and -1.1% for the United States market (cap-weighted) — 3rd highest of 20 in its peer set.
Growth Revenue grew 6.9% over the last twelve months (peer median +4.4%); the operating margin is 16.1% (peer median 12.8%).
Valuation It trades at 9.9× forward earnings against a peer median of 14.6× (4th cheapest of 20).
Price implies For today's price to make sense, revenue must grow about -8% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is -14 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 11.9 points above its cost of capital (7.2% WACC).
Backlog Backlog (remaining performance obligations) was $249M at 30 Sep 2026, up 33% on a year earlier — 0.0 years of trailing revenue. Backlog detail →
Credit Genpact has 2 bonds outstanding ($750M), rated BBB- by the agencies and trading like BBB- at a weighted spread of 98 bp.
Short interest Short interest is 6.6% of the free float (15 Oct 2026).
Next results Next results expected around 11 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $5.27B | $5.08B | $4.76B | $4.48B | $4.37B |
| Revenue growth | — | +7% | +6% | +2% | — |
| Gross profit | $1.94B | $1.82B | $1.65B | $1.53B | $1.50B |
| EBITDA | $931M | $864M | $772M | $714M | $678M |
| Net income | $583M | $552M | $514M | $631M | $353M |
| Free cash flow | $572M | $735M | $533M | $435M | $393M |
| Capital expenditure | $95.3M | $88.5M | $85.2M | $58.8M | $54.4M |
| Total debt | $1.41B | $1.76B | $1.45B | $1.50B | $1.70B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Genpact G | $7.07B | +30% | +7% | 16% | 9.9× | -7.5% |
| Accenture ACN | $154B | +44% | +6% | 15% | 17.8× | 3.7% |
| Cognizant CTSH | $28.9B | +26% | +5% | -1% | 10.5× | 0.8% |
| ExlService EXLS | $6.51B | +39% | +16% | 14% | 17.0× | 9.4% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | G | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +21.9% | +7.7% | 4th highest of 20 |
| 6-month return | +29.8% | +6.0% | 3rd highest of 20 |
| Distance from 52-week high | -13.1% | -13.0% | 11th highest of 21 |
| Revenue growth (TTM) | +6.9% | +4.4% | 8th highest of 21 |
| Operating margin | 16.1% | 12.8% | 6th highest of 21 |
| Forward P/E | 9.9× | 14.6× | 4th cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | -7.5% | 4.7% | 4th least demanding of 21 |
| Growth delivered (Del g) | +6.5% | +12.8% | 3rd lowest of 21 |
| Hurdle (Req g minus delivered) | -14.0 pp | -10.6 pp | 8th least demanding of 21 |
| ROIC minus cost of capital | +11.9 pp | +4.2 pp | 4th highest of 17 |
| EV / EBITDA | 8.6× | 10.1× | 8th cheapest of 19 |
| Net debt / EBITDA | 1.0× | 2.2× | 6th least indebted of 19 |
| Bond spread | 98 bp | 110 bp | 4th tightest of 10 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Genpact G | United States | $7.07B | +30% | +7% | 16% | 9.9× | -7.5% | +6.5% |
| Iss A/s ISS.CO | Denmark | $7.08B | +13% | +4% | 5% | 15.3× | -6.1% | +3.7% |
| Airtel Mobile Commerce AMC.L | United Kingdom | $7.05B | n/a | +30% | 48% | n/a | 11.5% | +30.3% |
| ALS ALQ.AX | Australia | $7.40B | -3% | +11% | 17% | 23.6× | 23.0% | +13.5% |
| Edenred EDEN.PA | France | $6.52B | +15% | +3% | 30% | 12.0× | -8.0% | +13.9% |
| Elis ELIS.PA | France | $6.44B | -12% | +5% | 13% | 12.0× | 10.1% | +11.3% |
| Nexi NEXI.MI | Italy | $5.93B | +18% | +1% | 13% | 7.0× | 1.5% | +30.5% |
| Beijing Compass Technology Development 300803.SZ | China | $5.91B | -23% | +12% | 0% | 174.6× | 46.9% | +25.3% |
| Spie SPIE.PA | France | $8.64B | -8% | +3% | 6% | 14.5× | 8.6% | +9.3% |
| CAE CAE.TO | Canada | $8.67B | +3% | +5% | 13% | 29.5× | 13.2% | +10.5% |
| Reply REY.MI | Italy | $5.46B | +41% | +6% | 13% | 17.0× | 2.9% | +14.4% |
| Securitas SECU-B.ST | Sweden | $9.22B | +4% | -5% | 7% | 12.3× | -4.9% | +7.5% |
| FTI Consulting FCN | United States | $5.33B | +19% | +8% | 10% | 18.7× | -3.6% | +9.0% |
| Booz Allen Hamilton BAH | United States | $10.1B | +11% | -6% | 9% | 13.3× | -7.0% | +7.4% |
| Aalberts AALB.AS | Netherlands | $4.87B | +6% | 0% | 10% | 14.6× | 12.9% | +3.4% |
| L&T Technology Services LTTS.NS | India | $4.79B | +13% | +2% | 15% | 29.4× | 31.0% | +15.1% |
| Dizal Pharmaceutical 688192.SS | China | $4.68B | +18% | +720% | 69% | 9.5× | -8.4% | +95.9% |
| Teleperformance TEP.PA | France | $4.60B | +3% | -3% | 10% | 5.0× | -10.2% | +12.2% |
| Brink's BCO | United States | $4.54B | +3% | +7% | 10% | 11.8× | 0.1% | +7.3% |
| Baycurrent 6532.T | Japan | $11.2B | +132% | +32% | 33% | 35.6× | 6.4% | +28.2% |
| Rentokil Initial RTO.L | United Kingdom | $11.9B | -26% | 0% | 14% | 16.9× | 8.2% | +13.4% |
Genpact has 2 bonds outstanding with $750M face value. The agencies rate it BBB-; its bonds trade like BBB-. Weighted yield 5.57%, a spread of 98 bp over government bonds.
Genpact reported $249M of remaining performance obligations at 30 Sep 2026, up 33% from a year earlier and up 26% from the previous quarter. That is 0.0 years of trailing revenue already under contract. Book-to-bill last quarter: 1.04.